One is that cytochrome P450 1A2 (CYP1A2) downregulation predicts recurrence of HCC and is associated with the oxidative stress pathway14, and the other is that cancer stem cells of HCC are characterized by the low proteasome activity and the low intracellular ROS level15. The gene discussed is CYP1A2; the disease is cancer.